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ABSTRACT 
 
 Because Glioblastoma Multiforme (GBM) usually results in death for most 
patients diagnosed, it is extremely important to delineate the molecular subtypes 
of GBM and determine molecular targets for therapy. Though there have been 
various previous studies that have determined subtypes for GBM, there are no 
studies that have determined molecular subtypes with a specific gene signature, 
as well as a specific miRNA signature. This study seeks to expand on the 
generally accepted and recently discovered subtype determinations, Neural, 
Proneural, Mesenchymal and Classical by elucidating a miRNA signature for 
each. In order to determine possible signature miRNAs, functional miRNA-target 
interactions were integrated with miRNA and mRNA/gene expression to infer 
mRNA-mediated miRNA-miRNA interactions, using conditional mutual 
information, for each subtype. The generated network represent miRNA 
modulation via common target mRNA. Each subtype had a group of most highly 
connected miRNAs. Because many of these highly connected have 
 vi 
experimentally validated evidence linking their regulation or dysregulation in 
GBM, those without any experimentally validated evidence could also be linked 
to GBM initiation or progression. Thus, these miRNAs could become future 
targets for therapeutic discovery and innovation. Further analysis is required to 
definitively classify miRNAs as linked to GBM in a significant fashion.   
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I. Introduction 
Glioblastoma Multiforme 
 Glioblastoma Multiforme, commonly termed glioblastoma or shortened to 
GBM, is the most common brain malignancy in humans. Most patients diagnosed 
with GBM do not survive a year after diagnosis , while mean survival rate is 
approximately 3.3% at 2 years after diagnosis (Ohgaki et al., 2004). Since it 
rarely metastasizes, GBM has a tendency to infiltrate surrounding brain tissue 
(Zhong, Paul, Kellie, & O’Neill, 2010). Unfortunately, the poor prognosis of the 
disease is due in part to its resistance to aggressive forms of conventional  
therapy, such as chemotherapy, radiation and surgery (Ohka, Natsume, & 
Wakabayashi, 2012). Due to infiltrative nature of the disease, surgical removal of 
cancerous cells is difficult (Koo, Martin, Schulz, Ronck, & Toussaint, 2012). Thus, 
delineating networks and pathways in the hopes of developing more effective 
therapies for molecular targets is extremely important. Much current research to 
better understand GBM has turned to high dimensional profiling studies. 
 The Cancer Genome Atlas (TCGA) is a data repository that aims to aid 
high dimensional profiling studies by providing catalogues of major genomic 
alterations in large cohorts of human tumors. Research centers and universities 
associated with The Cancer Genome Atlas Research Network collect tumor 
samples from patients and perform analyses while collecting associated clinical 
data. Such analyses are usually performed via microarray experiments to 
determine, for example, gene expression, DNA copy number, methylation 
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patterns, etc. Data is provided on TCGA website, and provides levels of desired 
processed data: raw data, normalized data and segmented and processed data. 
(“Comprehensive genomic characterization defines human glioblastoma genes 
and core pathways,” 2008).  
 Through the work and research created via leveraging of TCGA data, 
other data repositories and traditional tissue and clinical research, there are 
various classifications and subtypes of GBM (Huse, Phillips, & Brennan, 2011). 
GBM, itself, is a specific type of cancer in a broader category known as diffuse 
glioma. Such cancers are designated “diffuse” due to their invasive nature in the 
brain that precludes successful surgical resection. Though lower grade gliomas 
can be benign, they tend to eventually grow over the course of years and 
eventually threaten mortality of those afflicted. The World Health Organization 
(WHO) has developed a classification system for tumors that arise from 
dedifferentiation of mature cells or from precursors of neuronal or glial cells. 
According to the WHO classification system, there are three types of brain 
tumors based on tumor morphology: astrocytic, oligodendroglial and 
oligoastrocytic, also known as mixed. Further categorization is determined by a 
histological impression of tumor progression, known as grade. Grade II gliomas 
are indolent, while grade III gliomas are more malignant and grade IV 
classification indicates a fully malignant state. GBM is generally considered to be 
a WHO grade IV diffuse glioma.  GBM can develop from lower grade astrocytic 
tumors, but it also can develop de novo without previous lower grade 
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malignancies. Thus, GBM can be further classified into secondary and primary, 
respectively, which only apply to WHO grade IV tumors (Huse et al., 2011). The 
majority of GBM cases in older patients tends to be the primary type, while 
secondary GBM is quite rare and appears in younger patients. Despite differing 
clinical pathologies, primary and secondary GBM are morphologically and 
clinically indistinguishable (Furnari et al., 2007). The majority of samples from 
TCGA are classified as primary GBM. 
 Against this backdrop of histological and morphological classification, 
gene expression profiling has identified and seeks to solidify transcriptomal or 
molecular subtypes, especially due to the indistinguishable nature between 
primary and secondary GBM. A molecular classification system is essential for 
the conveyance of important information about disease prognosis and for 
targeted molecular therapy. However, there seems to be a lack of consensus on 
the number of subtypes in GBM (Kim, Huang, Park, Park, & Johnson, 2011; 
Phillips et al., 2006; Shen et al., 2012; Tang, Duan, Zhang, & Wang, 2013; 
Verhaak et al., 2010). Despite the disagreement and confusion, there are a few 
insights that can be asserted across all previous subtype studies. First, there are 
somewhere between two and five molecular subtypes of GBM. Second, virtually 
all literature on the matter has distinguished that there are at least two definitive 
subtypes that can be described as Proneural and Mesenchymal (Huse et al., 
2011). The two most cited studies that have determined the existence of the 
Proneural and Mesenchymal subtypes, while the most recent also specifies two 
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more subtypes known as Neural and Classical (Phillips et al., 2006; Verhaak et 
al., 2010). In Verhaak’s determination of subtype, he used data from TCGA 
which falls under the category of primary GBM, while in the study conducted by 
Phillips, all samples determined to be Mesenchymal were primary GBM samples 
and determined Proneural samples were both primary and secondary GBM 
(Huse et al., 2011). Further studies in GBM seek to clarify the categorization and 
subtyping of GBM. In the aforementioned subtype discoveries there has been 
very little to no elucidation of how miRNA’s affect these subtypes or how they can 
help classify these subtypes. 
 
MicroRNAs 
 In current research, miRNAs are a key interest for molecular target 
discovery. MiRNAs are small noncoding RNA’s that regulate gene expression via 
post translational effects. Usually miRNAs target the 3’UTR region of a gene 
transcript which leads either to transcript degradation or translational 
repression(Ruvkun, 2001). It is estimated that miRNAs exert regulation on over 
50% of human protein coding genes. In light of miRNA identification and 
exploration of miRNA function, recent significant research about miRNA 
involvement in cancer includes the discovery that miRNAs can act as oncogenes 
and tumor suppressors(Nohata, Hanazawa, Kinoshita, Okamoto, & Seki, 2013). 
Particularly, in GBM, miRNA expression signatures have been identified as both 
prognostic and diagnostic biomarkers (Srinivasan, Patric, & Somasundaram, 
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2011; Zhang et al., 2013). Considering the high patient mortality of GBM, there is 
an urgent need for the discovery of molecular targets that would facilitate 
development of new avenues for therapy.   
 
Conditional Mutual Information 
A key component for figuring out molecular pathways affecting GBM is 
determining the functional association between miRNAs and mRNA targets. 
There are various algorithms and computational methods that have been 
developed to determine the complementarity between miRNAs and targets. In 
addition to direct interactions between miRNA’s and targets, there is a level of 
secondary regulation. For, example one target could be expressed very highly 
and “sponge” up the expressed miRNA which prevents that miRNA from affecting 
its other targets and allows the other targets to “sponge” up the expression of 
other miRNAs that target them. Thus, miRNAs affect the expression of genes, 
and levels of expression of any miRNA will affect the expression of other 
miRNAs. Using these ideas, previous studies in prostate cancer and GBM have 
explored gene regulation of miRNA affecting mRNA expression as well as how 
mRNA can play the modulator role in miRNA regulation. Genes and mRNAs are 
referred to as MicroRNA-Response Elements (MRE) that modulate interactions 
among miRNAs. Generally, the modulator of miRNA expression is the 3’UTR of 
genes that are known as sponge modulators which absorb or bind  miRNAs and 
can be mRNAs and noncoding RNAs (Alshalalfa, 2012; Sumazin et al., 2011).  
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In both recent studies about miRNA networks, the investigators made 
inferences by estimating quantities from information theory: Mutual Information 
(MI) and Conditional Mutual Information (CMI). The MI is an estimator of the 
mutual dependence between two variables. It is dimensionless and can be 
considered as a reduction in uncertainty about one random variable given the 
knowledge of another.  If two variables have an MI that is 0 then the two 
variables are independent of one another(Latham & Roudi, 2009). The CMI 
computes the expected value of MI of two variables when given the third 
variable(Sumazin et al., 2011). In the study that is the blue print for this one, the 
CMI is computed for a miRNA-miRNA interaction given a mutual gene target 
between them as the conditional variable. Through such computation and further 
processing, a network of miRNA-miRNA interactions is created that can further 
reveal which miRNA’s are key in influence one another and can also reveal 
which miRNA’s could have an influence on genesis of the disease in question, in 
the case of the blueprint study, prostate cancer, and in the case of this study, 
GBM.  
Current Study and Objectives 
 In TCGA data repository, GBM has the greatest amount of available data. 
Because this study involved network analysis and statistical analysis and 
because larger data sets provide more significant and accurate results, GBM was 
chosen to be the subject of further analysis. Once this selection was made, a 
literature search was conducted to elucidate possible areas that needed further 
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exploration.  Focus was placed on miRNA’s as they are a recent discovery and 
have an influence on gene expression. 
 In order to determine a proper method for this study, computational 
research on other cancers was explored. Through this search, an interesting 
method conducted on prostate cancer was discovered, which explored mediated 
miRNA-miRNA interactions (Alshalalfa, 2012).  In Alshalalfa’s study, the method 
is actually a tinkered version of another method used in a study that also utilized  
GBM TCGA data (Sumazin et al., 2011). However, in the prostate cancer study, 
the author explored the interactions between miRNA’s as secondary regulators of 
other miRNA’s, while the study on GBM explored miRNA regulation on mRNA 
and gene expression. In Alshalalfa’s study, the conditional mutual information is 
computed between two miRNAs where the conditioning variable is a gene that 
acts as a target of both miRNAs, while in Sumazin’s study, the conditional mutual 
information is computed between a two genes or mRNAs and the conditioning 
variable is miRNA.  
 With the miRNA modulation network method in mind, the conundrum that 
plagues the current literature on GBM became more apparent: the lack of 
consensus about the number of subtypes in GBM (Huse et al., 2011; Kim et al., 
2011; Shen et al., 2012; Verhaak et al., 2010; Yan et al., 2011). Kim and his 
colleagues utilized miRNA expression data from TCGA and then used consensus 
clustering to determine subtypes of GBM based on miRNA expression. They 
asserted that there are five clinically and genetically distinct subtypes 
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characterized by distinct miRNA signatures that resemble the miRNA signatures 
of different neural precursor cell types. Shen and colleagues determined three 
subtypes by conducting integrative analysis and clustering of GBM using copy 
number data, gene expression data and methylation data, but not miRNA data. 
Yan and colleagues determined that there is an aggressive GBM subtype 
associated with CD133 expression but fail to integrate their discovery within the 
context of other subtypes. Verhaak and colleagues conducted analysis on gene 
expression of GBM using a consensus clustering algorithm followed by 
experimental validation and a corresponding histologIical analysis of determined 
subtypes. The study is the most cited and most recent paper on subtype 
classification and its subtype classifications are generally accepted. 
 Along with all of the aforementioned studies on subtype classification and 
miRNA regulation and involvement in GBM, there have been other studies that 
have explored miRNA regulatory networks. In one paper, the study on GBM 
TCGA data is conducted using feed forward loops that consist of miRNAs, 
transcription factors and their impact on GBM-related genes (Sun, Gong, Purow, 
& Zhao, 2012). In another study, gene expression signatures were used to 
represent miRNA activities and a genome wide miRNA pathway network was 
constructed and represent many highly connect miRNAs (Ooi et al., 2011).  In yet 
another study on TCGA GBM data, a lasso method was used to determine 
coexpression networks of mRNA and miRNA (H. Dong et al., 2010). In addition 
to all of the recent studies on miRNA networks, there have been other recent 
 9 
studies that have concluded that integrative analysis of various types of 
expression data is necessary for accurate subtype determination and 
classification (Shen et al., 2012; Tang et al., 2013). 
 All of the previously mentioned studies help to place this current study in 
context. Though there have been previous extensive studies on miRNA networks 
including one that has already used conditional mutual information, none of them 
take in to consideration the molecular subtypes of GBM and thus they seem to 
determine miRNA networks overall (H. Dong et al., 2010; Ooi et al., 2011; 
Sumazin et al., 2011; Sun et al., 2012). The one study that utilized miRNA 
expression for subclassification only considers miRNA expression and 
determined subtypes based on their expression (Kim et al., 2011). Additionally, 
most of the recent integrative analyses do not take into account both miRNA 
expression and gene expression when it comes to determining subtype (Shen et 
al., 2012). Though this study will not pursue integrative analyses of miRNA 
expression and gene expression to determine subtypes, it will build on the 
subtype classification system created by Verhaak and his colleagues. Then, this 
study will seek to employ the method of MRE-mediated miRNA-miRNA 
interactions to determine which miRNAs are important for each subtype. Though 
this study may not be as robust or significant as an integrative analysis study, it 
will still seek to clarify the muddled nature of GBM subtype classification and will 
hopefully provide insight into how the current, different proposals for subtype 
classification could possibly fit together. 
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II. Methods 
Datasets 
Datasets for this study were retrieved from TCGA. Level 3 miRNA 
expression sets were downloaded for all available samples. The unified scaled 
filtered data created by Verhaak and colleagues is also available on TCGA 
(https://tcga-data.nci.nih.gov/docs/publications/gbm_exp/). 
 
Microarray Experiments 
Assays on microarray platforms were performed on Agilent  8 x 15K 
Human miRNA-specific microarray platforms. Then the data was normalized and 
processed as described before it was made available on TCGA (“Comprehensive 
genomic characterization defines human glioblastoma genes and core 
pathways,” 2008). The gene expression data, before processing, by Verhaak and 
his colleagues also came from the data matrix on TCGA. After which Verhaak 
and his colleagues used factor analysis to combine gene expression from the 
various platforms. They then scaled and filtered the data down to 1,740 genes 
that they felt had the best expression for the purpose of further analysis. The 
unified, scaled filtered data was for 202 samples.  
 
Clustering 
 Clustering was conducted using the Bioconductor Package Consensus 
Cluster Plus which applied hierarchical clustering with agglomerative average 
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linkage. The distance metric was 1 – (Pearson’s Correlation Coefficient). The 
procedure was run over 1000 iterations with a subsampling ratio of 0.8 on the 
unified scaled filtered data. The R package sigclust was used to determine the 
significance between clusters. The silhouette function from the cluster package in 
R was used to filter out samples that didn’t adequately fit in a cluster. The data 
was further filtered in each subtype by correlating the clustered samples to 
Centroids data also available on TCGA on the page associate with the Verhaak 
paper. 
 
MicroRNA Target Interactions 
 In order to create as complete a list of experimentally validated targets as 
was humanly possible, a combination of mirTarBase(Hsu et al., 2011), miRecord 
(Xiao et al., 2009) and tarBase (Vergoulis et al., 2012) were used to construct a 
list of interactions between miRNAs and the genes from the unified data set.  
 
MRE-Mediated miRNA-miRNA Network Construction 
 In order to construct the networks conditional mutual information was 
computed where the mutual information was computed between two miRNAs 
and the gene expression represented the conditioning variable. In order to 
compute the conditional mutual information, the package infotheo from R was 
used. Infotheo is a package that provides basic computations of information 
theory.  
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 In order to determine the significance of each interaction, the gene 
expression was permuted a 1000 times and the conditional mutual information 
was recomputed. To determine a p-value, one just needs to observe between 
what expected values the computed value of conditional mutual information has 
fallen. In this method the 1000 permutations of gene expression helps to create a 
sortof null distribution with which one can determine p-value. For miRNA 
interactions that were the same, a P value was determined by converting the 
individual p-values to X2 statistic using Fisher’s method, X2 = -2∑ln(pk), where k = 
1…N where N is the total number of interactions for any two miRNAs. The 
networks were visualized in Cytoscape (Smoot, Ono, Ruscheinski, Wang, & 
Ideker, 2011). 
 
All data analyses and calculations were carried out in R. 
 
Enrichment Analysis 
Pathway enrichment analysis was conducted with the help of Database for 
Annotation, Visualization and Integrated Discovery (DAVID) which analyzed 
target gene pathways and then produces a file that could be opened in 
Cytoscape for network visualization.
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Results 
 
Consensus Clustering  
 After the Consensus Cluster Plus algorithm was run on the unified scaled 
filtered data, the results were compared to the same results from the original 
paper. The consensus matrices for each k show that at k values greater than 4 
that there are not very many samples that could be grouped into further 
categories (Figure 1). The results of clustering for k=4 clusters were slightly 
different from the original paper. When running clustering on the samples, there 
was high variability in the number of samples per cluster. The consensus 
matrices also show that some samples can be clustered in multiple clusters 
(Figure 1). The tracking plot of the clustered samples shows the variability in the 
in the cluster groupings (Figure2). When clustering results had similar 
proportions to the clustering results, further analysis ensued. The samples were 
clustered into in which the number of samples in each were 66, 59, 24 and 53. 
The samples were filtered for those appropriate to their cluster using the 
silhouette function which filtered the original 202 samples to 187 samples. 
Silhouette width is the ratio of each sample’s distance to samples in the same 
cluster to smallest distance to samples in the nearest neighboring sample. Only 
samples that had positive silhouette values were retained for further analysis. 
The number of samples per each cluster then became 58, 59, 24 and 46. 
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Figure 1: Consensus Clustering Matrices. Consensus clustering matrices of 
202 TCGA samples using unified, scaled and filtered data for k=3 to k=6. After 
k=4 clusters, there are very few samples that can be categorized into further 
clustering groups. 
 
 15 
 
Figure 2: Tracking plot of Categorization of samples. For each k that 
designates the number of clusters, this plot groups blocks of samples in the 
same cluster and creates a color block for each. The horizontal axis represents 
each of the samples. This plot shows which samples were clustered differently 
depending on the value of k during the clustering procedure. 
 
Further filtering using the Centroids data set to determine which set of 
samples determined which subtype resulted in a Classical subtype with 43 
samples, a Neural subtype with 19 samples, a Mesenchymal subtype with 53 
samples and a Proneural subtype with 55 samples. Thus, the original 202 
samples were filtered down to 170 samples that were split to accurately 
represent each subtype. In the original paper authored by Verhaak, they 
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concluded that there were 173 core samples that accurately represented each 
subtype. Though the breakdown was slightly different, the number of samples in 
the Proneural and Mesenchymal subtypes was quite similar. There were 54 
samples in Proneural subtype, 55 samples in the Mesenchymal, 27 samples in 
the Neural, and 37 samples in the Classical (Verhaak et al., 2010).  
 
Table 1: Between cluster p-values before clustered samples were matched with centroid clustered 
samples 
p values Proneural Classical Neural Mesenchymal 
Proneural     
Classical 2.709191E-16    
Neural 0.02757502 1.39E-05   
Mesenchymal 5.601699E-21 9.25E-11 5.46E-08  
. 
 
Table 2: Between cluster significance after cluster samples were matched with centroid clustered 
samples 
p values Proneural Classical Neural Mesenchymal 
Proneural     
Classical 5.84E-16    
Neural 0.01490888 2.17E-06   
Mesenchymal 6.46E-21 3.48E-13 8.90E-10  
 
 
Table 3: Between clusters significance from Verhaak study. 
p values Proneural Classical Neural Mesenchymal 
Proneural     
Classical 1.21E-10    
Neural 3.90E-03 3.70E-04   
Mesenchymal 5.93E-17 5.17E-06 2.69E-07  
  
 
Cluster significance was evaluated using SigClust and the significance 
was determined in a pair-wise fashion between clusters. The significance was 
determined both before (Table 1) and after (Table 2) centroid correlation analysis 
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was used to further filter the samples and after such analysis. The significance 
generally improved after centroid analysis except in one case, the significance 
between Proneural and Classical, increased. However, the p-value in between 
Proneural and Classical is still the same order of magnitude so the decline in 
significance is negligible. Compared to the original paper, the significance 
between clusterings greatly increased by orders of magnitude except in the case 
of the significance between Proneural and Neural for which the p-value increased 
by an order of magnitude. After the sample filtering and significance analyses, 
networks were created using target databases and the calculation of conditional 
mutual information.  
Through the conditional mutual information calculation and significance 
analysis of each interaction provided a framework for genome-wide inference of 
MRE modulators which led to the creation of a miRNA-miRNA posttranscriptional 
regulatory network for each GBM subtype. Each miRNA is represented as a 
node and the regulation between each miRNA is represented as undirected 
edges between nodes. These networks provide insights into indirect regulation 
that miRNAs can have on each other. If one miRNA affects a target, then 
miRNAs for that same target will experience some sort of indirect effect. Thus, 
one miRNA can modulate miRNAs that target the same gene. Target interaction 
data for experimentally validated targets was used to construct these networks. 
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miRNA-miRNA modulation network for Mesenchymal subtype 
 The miRNA-miRNA modulation network for the Mesenchymal subtype 
was constructed (Figure 3). There are 109 interactions among 76 nodes. The 
miRNAs in the network have an average of approximately 3 interactions where 
the number of interactions ranges from 1 to 13. Thus, on average there are 3 
targets that mediate interactions between miRNA pairs. The twelve miRNAs with 
highest connectivity were selected for further analysis: let-7a, miR-29b, miR-93, 
miR-205, miR-15a, miR-106b, miR-106a, miR-503, miR-21, miR-520b, miR-520h 
and miR-34a. Of these twelve, the lowest number of interactions is 6. The top 
twelve nodes connect with approximately 65% of the rest of the network.  
 
Figure 3:  MRE-mediated miRNA-miRNA interaction network using 
experimentally validated targets for the Mesenchymal suptype. These 
interactions show that certain miRNAs have more edges than others. The node, 
miR-34a, with the highest connectivity has only 13 edges. This network has 76 
miRNAs with 109 links. Size of the node and the size of the font on each node 
are proportional to the miRNA connectivity. 
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 In order to determine if the twelve miRNAs with the highest connectivity 
had any role in GBM, target genes were extracted from a combination of 
mirTarBase (Hsu et al., 2011) and miRecords (Xiao et al., 2009). The twelve 
miRNAs target 403 genes. Using DAVID online tool and the Enrichment Map 
plugin for Cytoscape, visualization of biological pathways, processes and terms 
associated with target genes is possible. From the enrichment map, target genes 
are involved in pancreatic cancer, mutagenesis, regulation of programmed cell 
death, regulation of cell cycle and regulation of cell proliferation (Figure 4). The 
cutoff value for the creation of the enrichment map was a very high p value (10-
13) to eliminate so many results for reasonable visualization. This enrichment 
analysis supports that the 12 miRNAs play a role in GBM by targeting genes in 
biological processes that are involved in cancer progression. Thus, the most 
important miRNAs from modulation network of Mesenchymal subtype in GBM 
are related to cancer progression. 
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Figure 4: Pathway Enrichment Analysis for target genes of 12 highly 
connected miRNAs of Mesenchymal subtype. The twelve highly connected 
miRNAs together target 403 genes. DAVID online tool was used to identify 
enriched pathways of the 403 genes using the cytoscape plugin, Enrichment 
Map. Target genes are enriched in certain cancers and in pathways related to, 
for example, certain cancers, apoptosis, cell cycle and regulation of programmed 
cell death. 
 
 
miRNA-miRNA modulation network for Proneural subtype 
 In the Proneural subtype, there are 96 interactions among 71 nodes. The 
miRNAs in this network have an average of approximately 3 interactions where 
the number of interactions ranges from 1 to 10. The eight miRNAs with the 
highest connectivity were selected for further analysis: miR-503, miR-520b, miR-
20a, miR-378, miR-20b, miR-155, miR-21 and miR-204. These miRNAs were 
selected for their high connectivity as well as the same cut off as the previous 
subtype where the lowest number of interactions for the most highly connected 
nodes is 6. The eight highly connected miRNAs comprise about 57% of the 
network. 
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Figure 5: MRE-mediated miRNA-miRNA interaction network using 
experimentally validated targets for the Proneural subtype. The node, miR-
503, with the highest connectivity has 10 edges. This network has 71 miRNAs 
with 96 links. There are eight miRNAs in this network that are the most highly 
connected. Size of the node and the size of the font on each node are 
proportional to the miRNA connectivity.  
 
 Using the same aforementioned process for Enrichment Analysis, the 8 
miRNAs target 379 genes. The target genes are associated with regulation of 
cellular differentiation, programmed cell death, regulation of apoptosis, pathways 
in cancer, regulation of cellular proliferation and proto-oncogenes (Figure 6). The 
p-value for the creation of this enrichment map was ~10-11. Again, the eight 
highly connected miRNAs are associated with pathways and genes related to 
cancer initiation and progression.  
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Figure 6: Pathway Enrichment Analysis for target genes of 8 highly 
connected miRNAs of Proneural subtype. The twelve highly connected 
miRNAs together target 379 genes. DAVID online tool was used to identify 
enriched pathways of the 379 genes using the Cytoscape plugin, Enrichment 
Map. Target genes are enriched in certain cancers and in pathways related to 
cancer progression and initiation. 
 
miRNA-miRNA modulation network for Classical subtype 
 In the Classical subtype, there are 89 interactions among 72 nodes. The 
miRNAs in this network have an average of approximately 2 interactions where 
the number of interactions ranges from 1 to 7. The eight miRNAs with the highest 
connectivity were selected for further analysis: miR-372, miR-20b, miR-34a, miR-
106b, miR-29b, miR-373, let-7b and miR-16 (Figure 7). These miRNAs were 
selected for their high connectivity; however the lowest connectivity of them is 5 
and not 6. The eight miRNAs are connected to about 40% of the network.  
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Figure 7: MRE-mediated miRNA-miRNA interaction network using 
experimentally validated targets for the Classical subtype. The nodes, miR-
20b and miR-372, with the highest connectivity have only 7 edges. This network 
has 72 miRNAs with 89 links. There are eight miRNAs in this network that are the 
most highly connected. Size of the node and the size of the font on each node 
are proportional to the miRNA connectivity. 
 
 The eight miRNAs target 578 genes. The target genes are associated with 
cell cycle, cell division, pathways in cancer, pancreatic cancer, bladder cancer, 
cell cycle control and mutagenesis (Figure 8). The p-value cut off for this 
enrichment analysis was ~10-10. The eight highly connected miRNAs could play a 
key role in GBM. 
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Figure 8: Pathway Enrichment Analysis for target genes of 8 highly 
connected miRNAs of Classical subtype. The eight highly connected miRNAs 
together target 578 genes. DAVID online tool was used to identify enriched 
pathways of the 578 genes using the Cytoscape plugin, Enrichment Map. Target 
genes are enriched in certain cancers and in pathways related to cancer 
progression and initiation, like cell cycle control, mutagenesis and cell division.  
 
miRNA-miRNA modulation network for Neural subtype 
In the Neural subtype, there are 104 interactions among 73 nodes. The 
miRNAs in this network have an average of approximately 3 interactions where 
the number of interactions ranges from 1 to 19. The nine miRNAs with the 
highest connectivity were selected for further analysis: miR-372, miR-20, miR-
20b, miR-93, miR-106a, miR-29b, miR-15a, miR-146a and miR-16 (Figure 9). 
These miRNAs were selected for their high connectivity the lowest connectivity 
among them was 6. The nine miRNAs are connected to about 61% of the 
network. The highest connected node, miR-106a in this network has almost twice 
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as many interactions as the next most highly connect node. Also, the miR-106a 
node is more highly connected than any of the nodes in any of the other 
networks. 
 
Figure 9: MRE-mediated miRNA-miRNA interaction network using 
experimentally validated targets for the Neural subtype. The node, miR-
106a, with the highest connectivity has 19 edges. This network has 73 miRNAs 
with 104 links. There are nine miRNAs in this network that are the most highly 
connected .Size of the node and the size of the font on each node are 
proportional to the miRNA connectivity. 
 
The nine miRNAs target 475 genes. The p-value cut off for this enrichment 
analysis was ~10-10. The target genes are associated with cell cycle, pathways in 
cancer, pancreatic cancer, programmed cell death, cell cycle control, regulation 
of apoptosis and mutagenesis (Figure 10). The nine highly connected miRNAs 
could play a key role in GBM. 
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Figure 10: Pathway Enrichment Analysis for target genes of 9 highly 
connected miRNAs of Neural subtype. The nine highly connected miRNAs 
together target 475 genes. DAVID online tool was used to identify enriched 
pathways of the 475 genes using the Cytoscape plugin, Enrichment Map. Target 
genes are enriched in certain cancers and in pathways related to cancer 
progression and initiation, like regulation of apoptosis, regulation of cell death, 
tumor suppressors and cell cycle processes. 
 
Important miRNAs occurring in more than one subtype 
Many of the highly connected miRNAs were similar across subtypes. MiR-
34a and -106b were highly connected in both Mesenchymal and Classical. MiR-
29b was highly connected in Mesenchymal, Classical and Neural. MiR-93, -106a 
and -15a were highly connected in both Mesenchymal and Neural. MiR-503, -
520b and -21 were highly connected in Mesenchymal and Proneural. MiR-20a 
was highly connected in Proneural and Neural. MiR-20b and -16 were highly 
connected in both Classical and Neural.
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Discussion 
Consensus Clustering  
Running consensus clustering on the unified, scaled and filtered data resulted 
in similar clustering as in the original paper but with some variability. The data 
had to be run a few times in order to reproduce the results from the Verhaak 
study. This variability probably results from the use of a different clustering 
algorithm than was used in the original study. The algorithm used in the original 
study is no longer an available package in R, but the replacement package, 
Consensus Cluster Plus, was created by the same programmer who is also an 
author on the original Verhaak study.  There were 173 samples labeled as core 
samples after clustering in the original study and silhouette width analysis. In this 
study, there were 187 samples after clustering and silhouette width analysis. 
However, the between cluster significance had greatly improved (except the 
significance between the Neural and Proneural subtypes) even though in this 
study, the clustering resulted in more samples. The discrepancy in significance 
can be attributed to a newer clustering package that could possibly have a better 
clustering method than the algorithm in the original paper. Additionally, the 
decrease in significance for the Neural subtype compared with the Proneural 
could be due to the extremely small sample size of the Neural subtype.  
Though there were more core samples after clustering, further analysis was 
necessary to determine labels for each clustered subtype. In the original study, 
Verhaak and his colleagues created a Centroid data set in which they determined 
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a list of genes that correlated highly to each subtype and then recorded the 
expression of each gene for each subtype. A correlation analysis was conducted 
for each subtype to determine gene expression for each sample in the subtype 
that was most similar to a particular subtype. The sample sets for each subtype 
were filtered further to ensure that only samples that correlated highly to a 
particular centroid remained in the data set. Thus, the sample size in total 
dwindles to 170, comparable to the core sample size in the original paper of 173. 
In addition, the significance between clusters improved after centroid analysis 
which shows that the centroid analysis and filtering helped to improve the data 
set.  
 There have been two major papers in the recent past that have sought to 
determine GBM subtypes: the study by Verhaak and the study by Phillips. In 
order to further understand the meanings of significance values between values, 
one should consider the comparison between the subtype classifications of the 
two major studies. When each classification system if applied to the other, 
Proliferative, Proneural, Mesenchymal versus Classical, Neural, Proneural, 
Mesenchymal, samples that were classified as Mesenchymal or Proneural were 
definitively still classified as Mesenchymal or Proneural, while the other subtype 
determinations were not as well resolved. There is no mapping between 
Verhaak’s Classical and Neural to Phillips’ Proliferative (Huse et al., 2011). Thus, 
it is possible that the samples in the Neural subtype in this study are not grouped 
as well as the samples in the Verhaak study, and the lower significance on the 
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part of the Neural versus the Proneural could be due to the fact that the samples 
have not been assigned to the best possible classification, but just a reasonable 
classification.  
 Generally, the networks of MRE-mediated miRNA-miRNA interactions 
using experimentally validated targets for each subtype were smaller than the 
same network in the blueprint study (Alshalalfa, 2012). This discrepancy can be 
attributed to differences in the sizes of the data sets. In the blueprint study, there 
were 139 samples, while in this study the number of samples per subtype that 
were used for network analysis was smaller. Additionally, the set of gene data 
used to determine miRNA interactions was scaled and filtered down, while the 
blueprint study seemed to use all available gene expression data for data 
analysis. Additionally, the cutoff p-value (p<.05) for the interaction network was a 
much higher value than the p-value cutoff used in the blueprint study. If the p-
value were not higher, there would be very few to no interactions in the network.   
 
miRNAs in the Mesenchymal subtype 
In the network of the Mesenchymal subtype, the most highly connected 
miRNA in the network is miR-34a. In a recent study, miR-34a has been identified 
as a regulator of TGF-β signaling in GBM. In the same study, miR-34a was 
identified as a discriminatory miRNA to help distinguish between the Proneural 
and the Mesenchymal subtype. Additionally, miR-34a has been identified as a 
tumor suppressor in Proneural GBM (Genovese et al., 2012; Silber et al., 2012; 
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Yin et al., 2013). In the Proneural Network, there is a miR-34a node of medium 
size. miR-34a has also been cited as existing in a region of frequent loss in GBM 
(Babic & Mischel, 2012). Since it is a tumor suppressor, the cancer phenotype in 
its absence is an expected outcome. 
Another highly connected node in the Mesenchymal subtype, miR-29b, 
has been found to inhibit invasion of GBM, and thus it is downregulated in such 
cells. The same study found the downregulation occurs in GBM cells and in 
CD133-positive cells (Cortez et al., 2010). This finding might be able to link the 
previously diagnosed lethal CD133 expressing subtype(Yan et al., 2011) to the 
Mesenchymal subtype which would help provide some clarity in the muddledness 
of GBM subtype distinction.  
Other highly connected miRNAs in the Mesenchymal subtype that appear 
in current literature in relation to GBM are: miR-93, miR-106a and miR-21. miR-
93 promotes tumor growth and angiogenesis and could become a potential 
therapeutic target (Fang et al., 2011). MiR-106 is considered to be a prognostic 
biomarker (Zhao et al., 2013). When miR-21 is silenced, the cytotoxic effect of 
the antiangiogenic drug, sunitinib, is enhanced (Costa et al., 2013), and it seems 
to control GBM cell growth (Wang et al., 2012). Finally, through integrative 
analyses of various grades of glioma samples miR-21 and miR-34a have been 
verified as markers for the Mesenchymal subtype (Ma et al., 2012). 
 
 
 31 
miRNAs in the Proneural Subtype 
 In the Proneural subtype, the most highly connected node is miR-503 
which has little recorded literature. MiR-20a is a reasonably connected node and 
has been confirmed to stabilize with a gene to establish a tumor suppressor 
pathway of gliomagenesis. In the aforementioned pathway, miR-20 can be 
considered another molecule that affects TGF-β (Chen et al., 2012).  One miR 
which has a high connectivity, miR-155, has been studied extensively. It is one of 
four other miRNAs that can serve as prognostic and predictive markers for 
survival in GBM patient (Qiu et al., 2013). MiR-155 is a potential target for cancer 
therapy because it is usually found overexpressed in GBM, and more specifically 
because it is found in both primary and secondary GBM and promotes tumor 
growth (D’Urso et al., 2012; Poltronieri, D’Urso, Mezzolla, & D’Urso, 2013). MiR-
21, as previously mentioned, had high connectivity in the Mesenchymal subtype, 
as well as the Proneural subtype. When miR-21 is inhibited, the proliferation and 
invasion of human glioma cells is inhibited (C. G. Dong et al., 2012). In the same 
vein, inhibition of miR-21 can increase the chemo-sensitivity of chemotherapy 
resistant glioma cells (Wong et al., 2012). 
 
miRNAs in the Classical Subtype 
 With respect to the Classical subtype, its miRNAs with the highest 
connectivity were the same as some of the Proneural and the Mesenchymal, 
such as miR-34a in Mesenchymal and -20b and -29b in Proneural. In the 
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Classical subtype, one of the more highly connected nodes, miR-16 is 
overexpressed in cancer samples that were categorized as WHO grade II and 
spontaneously progressed to WHO grade IV (Malzkorn et al., 2010). 
 
miRNAs in the Neural Subtype 
 The Neural miRNA with the highest connectivity, miR-106a, is also a node 
of high connectivity in the Mesenchymal subtype, along with miR-93, and -15a. 
MiR -20a/b and -29b also had high connectivity. In addition, the Neural suptype 
has a tendency to express miR-146a, which can inhibit glioma development by 
targeting neural stem cell differentiation and proliferation.(Mei, Bachoo, & Zhang, 
2011). 
 
Network Analysis Conclusion 
 Despite the limited size of the networks created, all key miRNAs for which 
there was literature available showed some sort of relationship or regulatory role 
on GBM. The connectivity is not necessarily directly correlated to the level of 
expression, but rather the number of miRNAs that indirectly regulate that miRNA. 
So even though, for example, miR-34a has high connectivity and is considered to 
be a tumor suppressor, the connectivity could just be representative of the 
suppression of expression of miR-34a. The literature search further validated the 
pathway enrichment analyses for each subtype. In all enrichment analyses, there 
were multiple nodes for each subtype related to some type of cancer or pathways 
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related to cancer, while the largest node on each was the phosphoprotein.  Since 
so many of the miRNAs relate to cancer and can be directly linked to GBM via 
literature search, highly connected miRNAs that did not have documentation in 
the literature deserve further experimental and computational analysis to 
determine their significance and function.  
 
Target Genes 
 After determining which miRNAs have the highest connectivity, the target 
genes of the most connected miRNAs were compiled for enrichement analysis 
using DAVID online tool. In the list of target genes for the Mesenchymal subtype, 
there were only two genes, PTEN and MET, that were also characteristic of the 
Mesenchymal subtype as described in the Verhaak study. In the list of target 
genes for the Proneural subtype, there were also only two genes, TP53 and 
CDKN1A, that were also characteristic of the Proneural subtype described in the 
original study. For the Classical subtype, EGFR, TP53 and Notch were the only 
genes also characteristic of the subtype as described by Verhaak. There were no 
genes in the target list of the Neural subtype that were also characteristic of the 
Neural subtype as described in the Verhaak study. One way to have avoided this 
problem would have been to use the scaled filtered data to determine which 
samples were representative of each cluster. But then, instead of using the 
scaled filtered data as the repository for gene targets and expressions, original 
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gene expression data could have been used to create more substantial networks 
using experimentally validated targets.  
 
Concluding Remarks 
 Interestingly, the most highly connected miRNAs for each subtype have 
never been grouped together or identified together in the same context with 
respect to GBM. An assertion that they are truly important or significant for each 
subtype cannot be made with full confidence due to the relatively small sizes of 
the networks. Though, it should be noted that for each subtype, some portion of 
the highly connected miRNAs have been linked to GBM as regulators or 
dysregulators of progression and initiation. So, to claim that some of the miRNAs 
that have never been identified with respect to GBM could be related to the 
initiation and progression of GBM might not be so farfetched. 
Unfortunately, unlike in the blueprint paper, this study does not include 
predictive networks of MRE-mediate miRNA –miRNA networks. These networks 
would help provide insight into the experimental networks and help to determine 
which miRNA nodes are truly hub nodes. The predictive networks would provide 
better analysis and conclusions, as to which miRNAs would be appropriate for 
pursuit of further study. After further analyses, it might be possible to determine 
which miRNAs are involved in cancer initiation and progression.  
Even though the predictive networks would have helped us to further 
determine what regulatory pathways and networks coexpress in each subtype, 
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there are so many processes and interactions occurring in a cell at any one time. 
In order to truly classify samples, it would make more sense to have as much 
information about the processes as possible, not just gene expression and not 
just miRNA expression combined with gene expression.  This study provides a 
foundation for future studies that would take into account gene expression, 
miRNA expression and other attributes of the genome in order to conduct 
integrative analyses that could finally provide definitive characterization for GBM 
subtypes.   
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